Skip to content


Document Actions

PILOTS PROJECTS AND FUNDED PROPOSALS 1999


INVESTIGATOR

PROTOCOL NAME

SUPPORT/FACILITIES

YEAR

Valerie Wojna, MD Melatonin in Patients with Partial Complex Seizures - Pilot  Study Outpatient Laboratory Support  1999-ongoing 
Inés García, MD Folate Metabolism In the Puerto Rican Population - Pilot  Study  Outpatient Biostatistical Laboratory  Support  1999-ongoing 
Loyda M. Meléndez,PhD Characterization of Viral and Host Factor in Progressor and Non- Progressor Puerto Rican Children - Pilot  Study  Biostatistical  Support  1999 
Yohana De Jesús, MD Respiratory Pathogens in Bronchoalveolar Lavage in Puerto Rican HIV Population - Pilot  Study  Biostatistical Support   1999- ongoing
José F. Rodríguez Orengo, PhD Plasma Homocysteine Levels and MTHFR Genes Mutations in Puerto Ricans and Their Possible Role in Artherosclerotic Cardiovascular Disease - Pilot  Study  Biostatistical Support   1999
María del Carmen González Ríos, MD  Characterization of Phenylketonuria Genetic Variants in Puerto Rico - Pilot  Study  Outpatient   1999-2000
Miguel A. Rivera Pérez, PhD Association Between Polymorphism in The ADP/ATP Translocator Gene and Cardiorespiratory Endurance - Pilot Study  Outpatient   1999
José F. Rodríguez Orengo, PhD Quantitation of Lamivudine /Azidothymidine  and Their Intracellular Metabolites in Peripheral Mononuclear Cells from HIV-Infected Patients  Inpatient  (24hr. PK Study)   1999 
Carmen Zorrilla, MD A Phase IV, Non-Comparative Study to Evaluate FORTOVASETM (saquinavir) Soft Gel Capsule (SGC) TID Regimen in Combination with Two NRTIs in HIV-Infected Women and Men Outpatient  (8hr. PK Study)  1999-2001 
Jorge Santana, MD  Pharmacology and Adherence Study:  A Substudy (A5006s) of ACTG 384  Outpatient  (12hr. PK Study)   1999-ongoing
Luz Guevara Ramos, MD Olanzapine versus Haloperidol in the Treatment of Acute Mania  Outpatient   1999-2000
Clemente Díaz, MD  Multicenter, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 2-Dose Regimen of High Titered (~50,000 PFU/0.5-mL) Process  Upgrade Varicella Vaccine (PUVV) in Subjects more than 13 Years of Age   Outpatient  Laboratory Support 1999-2001
Gishlaine Alfonso, MD Amyotrophic Lateral Sclerosis in Puerto Rico (ALS group)  Outpatient  Biostatistical Support   1999-ongoing
Esther A. Torres, MD, FACP Clinical Outcome of Chronic Hepatitis C (CHC) in the Cirrhotics  Biostatistical Support   1999 
Gildred Colón, MD  A Clinical Trial with Miglitol for the Treatment of Reactive Hypoglycemia  Biostatistical Support  1999 
Yohana De Jesús, MD Tuberculosis Surveillance in the University Hospital  Biostatistical Support  1999 
Esther A. Torres, MD, FACP Health Related Quality of Life in Inflammatory Bowel Disease in Puerto Rico  Biostatistical  Laboratory Support 1999 
Lourdes Peña, MD The Effect of Estrogen,  Gingko Biloba and Donepezil in the Treatment of Alzheimer's Dementia in Post-Menopausal Women Outpatient Biostatistical Support 1999 
Jorge Santana, MD Arm III Intensive Pharmacokinetics and Pharmacodynamics Substudy (ACTG A5060s) of ACTG 388 Outpatient  (12hr. PK Study)  1999-ongoing 
Irma Febo, MD A Phase I Trial of The Safety and Pharmacokinetics of FORTOVASETM(Saquinavir-SGC) Co-Administered with ZDV and 3TCTM in HIV Seropositive Pregnant Women During Gestation and Postpartum, and in Their Infants Post Maternal Dosing (NIHID) Outpatient  (8hr. PK Study)  1999-2003 
Edwardo Ramos, MD Muscle Strength, Muscle Cross-Sectional Area and Hormonal Levels in Adolescence Outpatient Laboratory Support 1999-2000
Alan Preston, PhD Determinants of Enviromental Tobacco in a Population of Puerto Rican Children Biostatistical Support  1999 
Esther A. Torres, MD, FACP A Single Blood Sample Study, in Conjunction with the ISIS 2302-CS9 Protocol, to Determine Polymorphisms to the ICAM-1 Gene, in Patients with Steroid-Dependent Crohn's Disease  Outpatient Laboratory Support 1999
Emma Fernández-Repollet, PhD Quantification of CD95 Expression in Type 1 Diabetic Puerto Rican Children  Outpatient  Biostatistical Support  1999-2002 
Esther A. Torres, MD, FACP Screening of TNF Microsatellite Polymorphisms as Potential Markers for Genetic Risk of Chronic Inflammatory Bowel Disease in Puerto Ricans- Pilot Study Outpatient Biostatistical Laboratory Support 1999-2002 
Esther A. Torres, MD, FACP  Saliva as a Sample Source for IRD Immunodiagnostic Assays Laboratory Support 1999-ongoing
 

The website is supported in part by Grant Number G12RR03051(RCMI Program, UPR Medical Sciences Campus) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH).
Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH.

Powered by Plone

This site conforms to the following standards: